Sie befinden sich hier

Inhalt

Targeting B cells in multiple sclerosis: lessons from anti-CD20 trials and the EBV connection

10.12.2026 | 13:00 - 14:00 Uhr

Ort: Haus 8, Ebene 3, Raum 1, Universitätsmedizin Mannheim, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim
Porträt von Øivind Torkildsen © 2026 European Charcot Foundation
Porträt von Øivind Torkildsen © 2026 European Charcot Foundation

MCTN – MI3 | IZN Lecture: "Targeting B cells in multiple sclerosis: lessons from anti-CD20 trials and the EBV connection", Prof. Øivind Torkildsen, Faculty of Medicine, Department of Clinical Medicine, University of Bergen, Norway

Øivind Torkildsen is a neurologist and Professor of Neurology at the University of Bergen, Norway, and a senior consultant at Haukeland University Hospital. He leads the Bergen Multiple Sclerosis Research Group and coordinates the EU-funded EBV-MS project, which investigates the role of Epstein–Barr virus (EBV) in the development and progression of multiple sclerosis (MS).

His research focuses on understanding the underlying mechanisms of MS and identifying new therapeutic strategies. With extensive experience in both clinical and preclinical research, Øivind Torkildsen has led numerous clinical trials investigating innovative treatment approaches for MS. His work aims to advance our understanding of the link between EBV infection and MS and to pave the way for new strategies for treatment and disease prevention.

Language: English

Flyer (Download)